Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-11-07 | 2018-02-26 | 28539 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Resolved | 2017-12-14 | 2018-02-26 | 32772 |
| APO-CAPTO TAB 25MG | 25MG | TABLET | Actual shortage | 2024-09-27 | 2025-01-31 | 238835 |
| APO-CAPTO TAB 25MG | 25MG | TABLET | Resolved | 2018-07-04 | 2018-10-05 | 54171 |
| APO-CAPTO TAB 25MG | 25MG | TABLET | Resolved | 2019-07-17 | 2019-09-16 | 89510 |
| APO-CARVEDILOL | 25MG | TABLET | Resolved | 2019-05-29 | 2019-08-12 | 85153 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2019-06-05 | 2019-08-12 | 85591 |
| APO-CARVEDILOL | 6.25MG | TABLET | Resolved | 2019-06-05 | 2019-08-12 | 85594 |
| APO-CARVEDILOL | 25MG | TABLET | Resolved | 2019-09-12 | 2020-09-21 | 93668 |
| APO-CARVEDILOL | 6.25MG | TABLET | Resolved | 2017-11-13 | 2018-05-27 | 29031 |
| APO-CARVEDILOL | 25MG | TABLET | Resolved | 2017-11-27 | 2018-05-27 | 30802 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2017-11-28 | 2018-05-27 | 30992 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187223 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-06-09 | 2023-07-27 | 194584 |
| APO-CARVEDILOL | 25MG | TABLET | Actual shortage | 2024-01-12 | 2024-01-12 | 215952 |
| APO-CARVEDILOL | 12.5MG | TABLET | Actual shortage | 2024-01-12 | 2025-04-01 | 215955 |
| APO-CARVEDILOL | 3.125MG | TABLET | Actual shortage | 2024-01-12 | 2024-12-14 | 215958 |
| APO-CARVEDILOL | 6.25MG | TABLET | Actual shortage | 2024-01-12 | 2024-12-02 | 215961 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-09-01 | 2023-11-17 | 203554 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2019-10-09 | 2020-09-21 | 95842 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |